Literature DB >> 29496381

Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.

Tiffeny T Smith1, Pranita D Tamma2, Tiffany B Do3, Kathryn E Dzintars4, Yuan Zhao5, Sara E Cosgrove6, Edina Avdic4.   

Abstract

We assessed risk factors for and outcomes of linezolid-resistant vancomycin-resistant Enterococcus faecium (LRVREF) bacteremia over 7 years. Thirty-four LRVREF cases were matched to 68 linezolid-susceptible VREF controls. The odds of bacteremia with LRVREF increased by 7% for each additional day of prior linezolid exposure.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Enterococcus faecium; Linezolid-resistant enterococci; VRE

Mesh：

Substances：

Year:  2018        PMID： 29496381     DOI： 10.1016/j.diagmicrobio.2018.01.027

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  8 in total

1.  Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus.

Authors:  Yaowen Li; Yu Peng; Na Zhang; Huiping Liu; Jun Mao; Yisong Yan; Shuaishuai Wang; Guang Yang; Yanyan Liu; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2022-08-30       Impact factor: 4.177

2.  Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis.

Authors:  Meijuan Chen; Hongying Pan; Yaling Lou; Zhe Wu; Jiajie Zhang; Yicheng Huang; Wei Yu; Yunqing Qiu
Journal:  Infect Drug Resist       Date:  2018-11-20       Impact factor: 4.003

3.  Antibiotic resistance of blood cultures in regional and tertiary hospital settings of Tyrol, Austria (2006-2015): Impacts & trends.

Authors:  Peter Kreidl; Thomas Kirchner; Manfred Fille; Ingrid Heller; Cornelia Lass-Flörl; Dorothea Orth-Höller
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

4.  Linezolid use in German acute care hospitals: results from two consecutive national point prevalence surveys.

Authors:  Tobias Siegfried Kramer; Frank Schwab; Michael Behnke; Sonja Hansen; Petra Gastmeier; Seven Johannes Sam Aghdassi
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-21       Impact factor: 4.887

5.  Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model.

Authors:  Caifen Qi; Shuangli Xu; Maomao Wu; Shuo Zhu; Yanyan Liu; Hong Huang; Guijun Zhang; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2019-11-12       Impact factor: 4.003

6.  Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy.

Authors:  Junyu Liang; Chuanyin Sun; Liqin Xu; Guanhua Xu; Heng Cao; Jin Lin
Journal:  Rheumatol Ther       Date:  2020-12-28

7.  Synergistic Combination of Linezolid and Fosfomycin Closing Each Other's Mutant Selection Window to Prevent Enterococcal Resistance.

Authors:  Lifang Jiang; Na Xie; Mingtao Chen; Yanyan Liu; Shuaishuai Wang; Jun Mao; Jiabin Li; Xiaohui Huang
Journal:  Front Microbiol       Date:  2021-02-09       Impact factor: 5.640

8.  Linezolid-Resistant Enterococcus spp. Isolates from Foods of Animal Origin-The Genetic Basis of Acquired Resistance.

Authors:  Urszula Zarzecka; Arkadiusz Józef Zakrzewski; Wioleta Chajęcka-Wierzchowska; Anna Zadernowska
Journal:  Foods       Date:  2022-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.